Company Information
USD
-
- (-%)
NASDAQ:MORF, MORPHIC HOLDING, INC.
Industry: Biotechnology
End of Day: 30 August 2024 GMT-4
Morphic Holding Inc is a biopharmaceutical company applying its insights into integrins to discover and develop a pipeline of oral small-molecule integrin therapeutics. Integrins are a target class with multiple approved injectable blockbuster drugs for the treatment of serious chronic diseases, including autoimmune, cardiovascular, and metabolic diseases, fibrosis, and cancer.
Address
35 Gatehouse Drive, A2
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Dr. Praveen P. Tipirneni, M.D.
CEO/Director
Dr. Bruce N. Rogers, PhD
President
Mr. Gustav A. Christensen
Chairman of the Board/Director
Mr. Joseph P. Slattery, C.P.A.
Director
Professor Dr. Norbert W. Bischofberger, PhD
Director
Dr. Martin William Edwards, M.D.
Director
Mr. Amir H. Nashat, PhD
Director
Mr. Robert E. Farrell, C.P.A.,Jr
Assistant Treasurer/Chief Accounting Officer/Senior VP, Divisional
Dr. Timothy A. Springer, PhD
Director/Founder
Dr. Nisha Nanda, PhD
Director
Dr. Marc Schegerin, M.D.
CFO/COO
Ms. Susannah Gray, M.B.A.
Director
Mr. William D. DeVaul, Esq.
General Counsel/Secretary
Ownership
Institution Holdings
FMR Inc
6,783,303 (13.557%)
FMR LLC
5,782,873 (11.557%)
Fidelity Management & Research Company LLC
3,496,382 (6.988%)
Wellington Management Company LLP
3,377,310 (6.750%)
Wellington Management Group, LLP
3,377,310 (6.750%)
BlackRock Inc
3,302,686 (6.600%)
State Street Corporation
2,564,058 (5.124%)
Point72 Asset Management, L.P.
2,504,383 (5.005%)
Vanguard Group Inc
2,321,046 (4.639%)
T. Rowe Price Associates, Inc.
2,222,628 (4.442%)
Individual Holdings
Dr. Timothy A. Springer, PhD
4,608,052 (10.056%)
Mr. Gustav A. Christensen
100,517 (0.330%)
Dr. Bruce N. Rogers, PhD
142,036 (0.286%)
Dr. Praveen P. Tipirneni, M.D.
42,013 (0.085%)
Dr. Marc Schegerin, M.D.
37,460 (0.075%)
Mr. Robert E. Farrell, C.P.A.
34,992 (0.070%)
Mr. William D. DeVaul, Esq.
23,029 (0.046%)
Mr. Joseph P. Slattery, C.P.A.
9,066 (0.018%)
Dr. Martin William Edwards, M.D.
2,376 (0.005%)
Mr. Amir H. Nashat, PhD
145 (0.000%)
Funds Holdings
SPDR® S&P Biotech ETF
1,903,684 (3.805%)
Fidelity Growth Company Commingled Pool
1,873,732 (3.745%)
Fidelity Growth Company Fund
1,453,814 (2.905%)
Fidelity Select Biotechnology Portfolio
1,296,799 (2.592%)
US Small-Cap Growth II Equity Comp
988,155 (1.975%)
T. Rowe Price New Horizons Fund
988,155 (1.975%)
iShares Russell 2000 ETF
905,927 (1.811%)
Pictet - Biotech
594,804 (1.189%)
Vanguard Institutional Extnd Mkt Idx Tr
594,469 (1.188%)
Vanguard Explorer Fund
536,966 (1.073%)
Make Smart Investment Choices
GoodWhale Pte. Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
